Preferred Buyer From
Ramimarc 1.5 contains Ramipril that blocks the counter-regulatory rise in angiotensin II triggered by diuretic therapy. The diuretics enhance antihypertensive action so patients who do not respond to monotherapy often do respond to combination therapy. Pharmacokinetically it is compatible with once-daily dosage and achieves maximum hypotensive effect approximately 4 hours after administration.
It is also available in: